Asset Manager

Updated:

HongShi Equity Fund

Zhang Lei's Shanghai-based growth equity firm targets consumer, healthcare, and enterprise software deals from an RMB-only fund structure.

HongShi Equity Fund

Zhang Lei founded Shanghai-based HongShi Equity Fund in 2017 after a decade at Goldman Sachs, where he focused on China private equity and special situations. The firm launched with an RMB-denominated fund that surpassed its initial target, drawing commitments from domestic institutional LPs including government guidance funds and insurance companies. HongShi operates as an independent GP with a classic buyout-and-growth equity mandate, distinct from the early-stage venture firms that dominate much of China's private capital landscape. The firm targets control and structured minority positions in mid-to-large-cap private companies across three verticals: consumer goods and services, healthcare services and medical technology, and enterprise software. HongShi typically deploys $30 million to $80 million in equity per transaction, with a preference for businesses generating at least RMB 200 million in revenue. Sector focus tilts toward discretionary consumption — restaurant chains, specialty retail, and consumer health — alongside selective IT services platforms. The firm structures deals through onshore RMB vehicles, limiting foreign LP exposure and aligning with domestic exit pathways on the Shanghai and Shenzhen exchanges. HongShi manages at least one commingled blind-pool fund, though the firm does not publicly disclose assets under management or total capital deployed. The investment team is lean by design, reflecting the founder's operating-partner philosophy: Zhang Lei maintains that portfolio company value creation relies more on post-acquisition operational involvement than on large investment teams. No adjacent philanthropic vehicles or club-deal networks have been publicly associated with the firm. In September 2024, HongShi completed a partial exit from a consumer health portfolio company via a Shenzhen IPO, according to regulatory filings. HongShi's structural differentiator lies in its RMB-only fund architecture during a period when many China GPs raced to raise USD vehicles. By forgoing foreign capital, the firm sidestepped the currency-control and exit-approval complexities that complicated USD-fund distributions after 2021. This onshore purity keeps HongShi aligned with domestic listing rules and the priorities of China's state-backed LPs — a positioning that functions as both a constraint and a competitive moat in the current regulatory environment.

General information

Firm type

Asset Manager

Year founded

2017

AUM

Undisclosed

Location

Region

Asia

Country

China

City

Shanghai

Corporate office

Shanghai, China

Principals

Zhang Lei

Founder

Sector focus

ConsumerHealthcare ServicesEnterprise Software

Frequently asked questions

Who runs investment decisions at HongShi Equity Fund?

Founder Zhang Lei leads all investment decisions. Before launching HongShi in 2017, he spent roughly ten years at Goldman Sachs in China-focused private equity and special situations. The firm operates with a lean team structure, reflecting Zhang's view that post-acquisition operational involvement matters more than investment team headcount.

How is HongShi Equity Fund structured — does it raise USD or RMB funds?

HongShi raises only RMB-denominated funds, drawing commitments from domestic Chinese institutional investors including government guidance funds and insurers. This onshore-only structure avoids the currency-control and regulatory hurdles that USD funds face when exiting Chinese portfolio companies. It also aligns the firm with domestic IPO pathways on the Shanghai and Shenzhen exchanges.

What investment stages and check sizes does HongShi target?

HongShi writes equity checks between $30 million and $80 million for control or structured minority positions. The firm targets mid-to-large-cap private companies that typically generate at least RMB 200 million in revenue. Its mandate covers later-stage growth equity and buyout transactions, not early-stage venture capital.

Which sectors does HongShi Equity Fund explicitly avoid?

Public disclosures show no investment activity in real estate, infrastructure, or natural resources. The firm's stated focus remains on consumer goods and services, healthcare services and medical technology, and enterprise software. Hard-tech sectors like semiconductors and advanced manufacturing — heavily targeted by other China GPs — do not appear in HongShi's disclosed mandate.

Does HongShi participate in fund commitments or only direct deals?

HongShi deploys capital exclusively through direct equity investments in portfolio companies. There is no public record of the firm making fund commitments to other GPs or participating in fund-of-funds structures.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on family offices?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo